Health Canada drug identification number

DIN 02555050 — TALZENNA 0.1 MG

TALZENNA is a capsule of Talazoparib marketed by PFIZER CANADA ULC. The full Talazoparib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02555050
Brand name
TALZENNA
Active ingredient
Talazoparib
Strength
0.1 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
PARP inhibitor (poly ADP-ribose polymerase inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Talazoparib products

DINBrandStrengthFormManufacturerStatus
02492032 TALZENNA 0.25 MG CAPSULE PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.